Biosynex (FRA:0DL) Institutional Ownership: 0.12% (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0DL Biosynex SA FRA:0DL
53 GF Score
Price €0.86
GF Value €2.25
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Biosynex Institutional Ownership?

Biosynex FRA:0DL -0.92% 53 Institutional Ownership is 0.12% as of Aug. 07, 2026. GuruFocus rates FRA:0DL with a GF Score™ of 53/100 and a GF Value™ of €2.25 (Possible Value Trap). The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biosynex's institutional ownership is 0.12%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biosynex's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biosynex's Float Percentage Of Total Shares Outstanding is 0.00%.

Biosynex Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Biosynex's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosynex Institutional Ownership Chart

Biosynex Historical Data

The historical data trend for Biosynex can be seen below:

2025-03-31 2025-04-30 2025-05-31 2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31
Institutional Ownership 0.56 0.40 0.40 0.40 0.40 0.40 0.18 0.12 0.12 0.12
FRA:0DL
53GF Score
Biosynex SA FRA:0DL
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosynex Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.12% mean?
Biosynex (FRA:0DL) has a Institutional Ownership of 0.12% as of Aug. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Biosynex and its competitors.
Is Biosynex's Institutional Ownership too high?
Biosynex's current Institutional Ownership is 0.12%. Overall, Biosynex has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biosynex's Institutional Ownership compare to ABT and SYK?
Biosynex's Institutional Ownership of 0.12% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Biosynex and its competitors. Biosynex's current Institutional Ownership is 0.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosynex stock overvalued right now?
Based on GuruFocus' analysis, Biosynex (FRA:0DL) is currently considered Possible Value Trap. The stock's GF Value™ is €2.25, compared to a current price of €0.86 — trading 61.7% below its estimated fair value. The current Institutional Ownership is 0.12%. Biosynex's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Biosynex (FRA:0DL), the current Institutional Ownership is 0.12% as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biosynex (FRA:0DL) Overvalued in 2026?

Based on GuruFocus' analysis, Biosynex stock appears to be undervalued. The current stock price of €0.86 is trading 61.7% below its estimated GF Value™ of €2.25. GuruFocus considers Biosynex to be Possible Value Trap.

Key valuation signals for FRA:0DL:

  • Institutional Ownership: 0.12%
  • GF Value™: €2.25 vs. price of €0.86 (61.7% below fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the FRA:0DL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biosynex Business Description

Other Exchanges ALBIO:France
Address 22 Boulevard Sebastien Brant, Illkirch, FRA, 67400
Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.
53GF Score

Get the complete analysis for FRA:0DL

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.86
Price
€2.25
GF Value